From September 17 to 19, 2025, Vitafoods Asia, the most influential nutraceutical and functional food exhibition in Asia, was grandly held in Bangkok, Thailand.

Norwegian premium dietary nutrition brand NYO3 has been invited to exhibit for the second consecutive year, and together with global krill oil leader Aker BioMarine, is making the Asia debut of its innovative brain anti-aging product—NYO3 Lysophosphatidylcholines DHA Softgel. With its cutting-edge “Norway L3” phospholipid innovation portfolio, the brand attracted significant attention from industry experts and distribution partners alike.

The collaboration between NYO3 and Aker BioMarine is deeply rooted in Norway’s leading position in marine biotechnology and anti-aging research. As the global leader in sustainable Antarctic krill harvesting and phospholipid extraction technologies, Aker BioMarine currently holds over 70% of the world’s krill harvesting quota. Building on Norway’s reputation for pure nutrition and science-based anti-aging, NYO3 has established itself with exceptional product strength and forward-looking innovation.

According to Euromonitor International (Shanghai) Ltd., NYO3 was recognized as “a leading krill oil brand in terms of manufacturing sales value for two consecutive years globally (2023–2024)” and “the No.1 high-phospholipid krill oil brand globally in 2024”. The brand has also been qualified for the Orivo origin verification program for five consecutive years, further strengthening its credibility and trust among global consumers.

With a continued focus on phospholipid-based anti-aging applications, NYO3 integrates krill phospholipids with endogenous anti-aging ingredients to achieve cell-level targeted absorption. Together, NYO3 and Aker BioMarine are committed to delivering the cutting-edge achievements of Norwegian marine nutrition science to consumers worldwide.

According to a report by Grand View Research, the global marine phospholipid market is expected to surpass USD 500 million by 2030. As a leader in the global krill oil industry, NYO3 has joined forces with Aker BioMarine, combining their respective strengths to launch the first LPC product independently developed and manufactured by a Norwegian brand —NYO3 Lysophosphatidylcholines DHA Softgel. Leveraging NYO3’s years of expertise in the Asian market, this product will make its debut in China, a country with immense demand. On this occasion, Aker BioMarine officially granted the certification of “The only certified LPC-based Brain Gold product in China”, underscoring its technological uniqueness and market-leading position in China.

It features the fourth-generation LYSOVETA™ patented ingredient, with Lysophosphatidylcholine (LPC) as a phospholipid form of DHA. LPC-DHA is scientifically recognized as the most efficient form of DHA for brain absorption to date [Cui XY et al., Food Funct., 2020].

LPC-DHA can actively cross the blood-brain barrier through the body’s intrinsic transporter protein Mfsd2a, ensuring highly efficient delivery to the brain. Compared with conventional esterified DHA, LPC-DHA demonstrates twice the absorption efficiency, with precise delivery to the brain and retina, where it directly supports neuronal repair and regeneration [Sugasini D. et al., Invest. Ophthalmol. Vis. Sci., 2017].

Research further indicates that LPC-DHA can enhance memory by up to sevenfold and help delay brain degeneration, offering a forward-looking nutritional approach to the prevention of Alzheimer’s disease [Sugasini D. et al., Scientific Reports, 2023].

During the exhibition, NYO3 also unveiled two additional phospholipid-based anti-aging innovations — NYO3 Antarctic Supreme Phospholipids Krill Oil and NYO3 Efficient Liver Metabolism.

The Antarctic Supreme Phospholipids Krill Oil sets a new industry benchmark by elevating phospholipid content to a record 80%, with a zero-additive, all-natural formulation designed for cell-level targeted absorption. Meanwhile, Efficient Liver Metabolism combines marine phospholipids, fucoxanthin, milk thistle, and curcumin, delivering an upgraded “Cleanse, Purify, Nourish” formula that provides multi-dimensional support for liver health.

Together with the NYO3 Lysophosphatidylcholines DHA Softgel, the three products form the “Norway L3: A New Era in Anti-Aging Nutrition” portfolio, empowering brain, liver, and lipid health with cutting-edge Norwegian science.

Through its participation in Vitafoods Asia, NYO3 has further strengthened its presence in the Asia-Pacific premium nutrition market. As global demand for health and wellness products continues to rise, NYO3 will maintain phospholipid technology at the core of its innovation, collaborating with world-leading companies such as Aker BioMarine to drive Norwegian anti-aging nutrition toward a future of precision, personalization, and internationalization.

1.Data source: Euromonitor International (Shanghai) Ltd. measured in terms of manufacturing sales value in retail channels in 2023-2024globally. Krill oil refers to dietary supplement products containing krill oil raw materials as the main ingredient (excluding non-consumer product krill oil raw materials sold B2B for incorporation in other supplements). Based on custom research conducted in May 2025.

2.Data source: Euromonitor International (Shanghai) Ltd., measured in terms of manufacturing sales value in retail channels in 2024 globally. High-phospholipid Krill oil refers to dietary supplement products containing krill oil raw materials as the main ingredient (excluding non-consumer product krill oil raw materials sold B2B for incorporation in other supplements), with a phospholipid purity (phospholipid con-tent per unit of krill oil) exceeding 50%. Based on custom research conducted in May 2025.

3.Cui XY, Jiang S, Jin CC, Yang JY, Zhao YC, Xue CH, Wang YM, Zhang TT. Comparative analyses of EPA-phosphatidylcholine, EPA-lysophosphatidylcholine, and DHA-lysophosphatidylcholine on DHA and EPA repletion in n-3 PUFA-deficient mice. Food Funct. 2020;11(5):4345-4356. doi:10.1039/D0FO00269F

4.Sugasini D, Poorna cR, Yalagala PcR, Subbaiah Pv. Efficient enrichment of retinal DHA with dietaryysophosphatidylcholine DHA: Potential application for retinopathies. invest Ophthalmol VisSci.2017;58(4):1950-1959.doi:10.1167/iovs.16-21036

5.Sugasini D., et al., “Improvement of retinal function in Alzheimer disease model by dietary LPC-DHA/EPA”, Scientific Reports, 2023.

Media Contact
Company Name: NYO3 International AS
Contact Person: Derek Sung
Email: Send Email
Country: Thailand
Website: https://nyo3.com